Biomet’s Earnings

From Reuters:

Biomet Inc. (BMET) on Wednesday said its quarterly earnings rose on sales growth for its orthopedic reconstructive and dental reconstructive implants.
The Warsaw, Indiana-based maker of orthopedic devices said its earnings rose to $101.3 million, or 41 cents per share, in its fiscal second quarter ended Nov. 30. In the year-ago period, the company earned $91.2 million, or 36 cents per share.
The consensus estimate on Wall Street was for a profit of 43 cents per share, according to Reuters Estimates.
Biomet said sales in the quarter rose 8 percent to $494.7 million.
It said it expects third-quarter earnings per share will rise to a range of 43 cents to 44 cents a share, slightly below analyst estimates of 46 cents a share. It expects sales in the quarter to be between $510 million to $520 million.

Posted by on December 21st, 2005 at 5:23 am


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.